REPLIMUNE GROUP, INC. Interest Expense on Debt
REPLIMUNE GROUP, INC. (REPL) reported Interest Expense on Debt of $2.58 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpenseDebt · last filed 2026-08-14
- REPLIMUNE GROUP, INC. interest expense, debt for the quarter ending 2026-06-30 was $2.58M, a 74.98% increase year-over-year.
- REPLIMUNE GROUP, INC. interest expense, debt for the quarter ending 2026-03-31 was $2.37M, a 62.01% increase year-over-year.
- REPLIMUNE GROUP, INC. interest expense, debt for the quarter ending 2025-12-31 was $1.47M, a 1.10% increase year-over-year.
- REPLIMUNE GROUP, INC. interest expense, debt for the quarter ending 2025-09-30 was $1.49M, a 3.48% increase year-over-year.
- REPLIMUNE GROUP, INC. interest expense, debt for fiscal 2026 was $6.80M, a 17.68% increase from fiscal 2025.
- REPLIMUNE GROUP, INC. interest expense, debt for fiscal 2025 was $5.78M, a 28.42% increase from fiscal 2024.
- REPLIMUNE GROUP, INC. interest expense, debt for fiscal 2024 was $4.50M, a 129.09% increase from fiscal 2023.
- REPLIMUNE GROUP, INC. interest expense, debt for fiscal 2023 was $1.96M.
| Period end | Interest Expense, Debt 3 month | Interest Expense, Debt 6 month | Interest Expense, Debt 9 month | Interest Expense, Debt 12 month |
|---|---|---|---|---|
| 2026-06-30 | $2.58M 10-Q · filed 2026-08-14 | $4.95M derived: sum of 2 quarters · filed 2026-08-14 | $6.41M derived: sum of 3 quarters · filed 2026-08-14 | $7.90M derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | $2.37M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $3.83M derived: sum of 2 quarters · filed 2026-06-29 | $5.32M derived: sum of 3 quarters · filed 2026-06-29 | $6.80M 10-K · filed 2026-06-29 |
| 2025-12-31 | $1.47M 10-Q · filed 2026-02-03 | $2.95M derived: sum of 2 quarters · filed 2026-02-03 | $4.43M 10-Q · filed 2026-02-03 | $5.89M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-09-30 | $1.49M 10-Q · filed 2025-11-06 | $2.96M 10-Q · filed 2025-11-06 | $4.42M derived: sum of 3 quarters · filed 2026-08-14 | $5.87M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | $1.48M 10-Q · filed 2026-08-14 | $2.94M derived: sum of 2 quarters · filed 2026-08-14 | $4.39M derived: sum of 3 quarters · filed 2026-08-14 | $5.82M derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $1.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-06-29 | $2.91M derived: sum of 2 quarters · filed 2026-06-29 | $4.35M derived: sum of 3 quarters · filed 2026-06-29 | $5.78M 10-K · filed 2026-06-29 |
| 2024-12-31 | $1.45M 10-Q · filed 2026-02-03 | $2.89M derived: sum of 2 quarters · filed 2026-02-03 | $4.31M 10-Q · filed 2026-02-03 | $5.73M derived: sum of 4 quarters · filed 2026-02-03 |
| 2024-09-30 | $1.44M 10-Q · filed 2025-11-06 | $2.86M 10-Q · filed 2025-11-06 | $4.28M derived: sum of 3 quarters · filed 2025-11-06 | $5.29M derived: sum of 4 quarters · filed 2025-11-06 |
| 2024-06-30 | $1.43M 10-Q · filed 2025-08-07 | $2.84M derived: sum of 2 quarters · filed 2025-08-07 | $3.85M derived: sum of 3 quarters · filed 2025-08-07 | $4.81M derived: sum of 4 quarters · filed 2025-08-07 |
| 2024-03-31 | $1.41M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-22 | $2.43M derived: sum of 2 quarters · filed 2025-05-22 | $3.38M derived: sum of 3 quarters · filed 2025-05-22 | $4.50M 10-K · filed 2025-05-22 |
| 2023-12-31 | $1.01M 10-Q · filed 2025-02-12 | $1.97M derived: sum of 2 quarters · filed 2025-02-12 | $3.08M 10-Q · filed 2025-02-12 | $4.10M derived: sum of 4 quarters · filed 2025-02-12 |
| 2023-09-30 | $955.00K 10-Q · filed 2024-11-12 | $2.07M 10-Q · filed 2024-11-12 | $3.09M derived: sum of 3 quarters · filed 2024-11-12 | $4.03M derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | $1.11M 10-Q · filed 2024-08-08 | $2.14M derived: sum of 2 quarters · filed 2024-08-08 | $3.08M derived: sum of 3 quarters · filed 2024-08-08 | $3.08M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.02M derived: 10-K 12 month − 10-Q 9 month · filed 2024-05-16 | $1.96M derived: sum of 2 quarters · filed 2024-05-16 | $1.96M derived: sum of 3 quarters · filed 2024-05-16 | $1.96M 10-K · filed 2024-05-16 |
| 2022-12-31 | $941.00K 10-Q · filed 2024-02-08 | $941.00K derived: sum of 2 quarters · filed 2024-02-08 | $941.00K 10-Q · filed 2024-02-08 | $941.00K derived: sum of 4 quarters · filed 2024-02-08 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-07 | $0.00 10-Q · filed 2023-11-07 | $0.00 derived: sum of 3 quarters · filed 2023-11-07 | $0.00 derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 2 quarters · filed 2023-08-03 | $0.00 derived: sum of 3 quarters · filed 2023-08-03 | $0.00 derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-05-18 | $0.00 derived: sum of 2 quarters · filed 2023-05-18 | $0.00 derived: sum of 3 quarters · filed 2023-05-18 | $0.00 10-K · filed 2023-05-18 |
| 2021-12-31 | $0.00 10-Q · filed 2023-02-09 | $0.00 derived: sum of 2 quarters · filed 2023-02-09 | $0.00 10-Q · filed 2023-02-09 | $1.00K derived: sum of 4 quarters · filed 2023-02-09 |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-04 | $0.00 10-Q · filed 2021-11-04 | $1.00K derived: sum of 3 quarters · filed 2022-05-19 | $248.00K derived: sum of 4 quarters · filed 2022-05-19 |
| 2021-06-30 | $0.00 10-Q · filed 2021-08-06 | $1.00K derived: sum of 2 quarters · filed 2022-05-19 | $248.00K derived: sum of 3 quarters · filed 2022-05-19 | $534.00K derived: sum of 4 quarters · filed 2022-05-19 |
| 2021-03-31 | $1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-05-19 | $248.00K derived: sum of 2 quarters · filed 2022-05-19 | $534.00K derived: sum of 3 quarters · filed 2022-05-19 | $818.00K 10-K · filed 2022-05-19 |
| 2020-12-31 | $247.00K 10-Q · filed 2022-02-03 | $533.00K derived: sum of 2 quarters · filed 2022-02-03 | $817.00K 10-Q · filed 2022-02-03 | |
| 2020-09-30 | $286.00K 10-Q · filed 2021-11-04 | $570.00K 10-Q · filed 2021-11-04 | ||
| 2020-06-30 | $284.00K 10-Q · filed 2021-08-06 | |||
| 2020-03-31 | $734.00K 10-K · filed 2021-05-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vor Biopharma Inc. (VOR) | United States | $1.091B | 1.60 |
| MeiraGTx Holdings plc (MGTX) | United States | $1.061B | 16.10 |
| Monte Rosa Therapeutics, Inc. (GLUE) | United States | $1.002B | -12.81 |
| Cullinan Therapeutics, Inc. (CGEM) | United States | $0.993B | -5.72 |
| Odyssey Therapeutics, Inc. (ODTX) | United States | $0.960B | |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Sana Biotechnology, Inc. (SANA) | United States | $0.886B | -4.92 |
| Candel Therapeutics, Inc. (CADL) | United States | $0.885B | -8.86 |
| Attovia Therapeutics, Inc. (ATTO) | United States | $0.828B |